^
    Apply
    Study to Compare the Effects of AZD9496 vs Fulvestrant in Breast Cancer. (NCT03236974)
    Phase 1
    AstraZeneca
    Completed
    Last update posted :
    02/06/2020
    Initiation :
    10/05/2017
    Primary completion :
    02/12/2019
    Completion :
    02/12/2019
    HER-2 • ER • PGR
    |
    HER-2 negative • ER expression • PGR expression
    |
    fulvestrant • AZD9496
    AZD9496 First Time in Patients Ascending Dose Study (NCT02248090)
    Phase 1
    AstraZeneca
    Completed
    Last update posted :
    06/24/2019
    Initiation :
    10/22/2014
    Primary completion :
    01/31/2017
    Completion :
    04/03/2019
    HER-2 • ER
    |
    ER positive • HER-2 negative
    |
    AZD9496